Aurobindo Pharma gets nod from US health regulator for pain reliever Ibuprofen
Updated : July 02, 2018 12:38 PM IST
The approved product is a generic equivalent of Pfizer's Advil Liqui-Gels Capsules.
The product will be launched in September 2018.
Stock of Aurobindo Pharma was trading 0.61 percent higher.